Antivirus online is crucial to guard your computer from malware and also other threats. These types of programs damages your...
The way to select the Best Cost-free VPN
If you want for being protected although browsing the web, you should choose the best no cost VPN to meet...
Shipment received: At-home COVID tests delivered to Erie 1 BOCES
The at-home kits were divvied up and picked up by 19 different school districts in Erie County for distribution.
Access Bio, Inc. CareStart™ COVID-19 Detection Kits Efficacy in New SARS-CoV-2 Variant Omicron
Based on sequence analysis and Omicron recombinant protein test, Omicron variant does not have influence on the target region of CareStart™ COVID-19 Rapid and PCR Tests.
Casinoland Gambling establishment The us Evaluate
Content Online casino Informatie Casinoland Facts What Greatest Free Spots System Substances? Casinoland Are located Gambling house Found at Real...
Simply no Lodge Online casino Bonus Devoid of Utmost Funds
Content Brand-new Neo Gamstop Online casino Caribbean Hardly any Deposit Bonus offer Ignition Internet casino Online codes Seeking out Very...
MCKESSON MEDICAL SURGICAL SIGNS NATIONAL DISTRIBUTION AGREEMENT
INTRIVO DIAGNOSTICS SECURES NATIONAL DISTRIBUTION AGREEMENT WITH MCKESSON MEDICAL-SURGICAL FOR ACCESS BIO CARESTART™ COVID-19 TESTS
ANNOUNCEMENT OF THE RECORD DATE FOR DETERMINING SHAREHOLDERS
In accordance with Article 16 (1) of the “Korean Depository Receipt Agreement” signed between Access Bio and Korea Securities Depository on March 11, 2013, the Record Date for determining shareholders in 2020 is December 31, 2020.
CONCORDANCE HEALTHCARE SOLUTIONS AND NDC INK NATIONAL DISTRIBUTION AGREEMENTS
Major supply chain agreements will ensure broad access to rapid testing solutions for patients and healthcare providers across US
FDA GREENLIGHTS ACCESS BIO’S 10-MINUTE COVID-19 ANTIGEN TEST
Emergency Use Authorization Granted for CareStartTM Point-Of-Care Kit
CARESTART™ IGM/IGG ANTIBODY TEST GRANTED EUA AUTHORIZATION
Global Leader in Infectious Disease Diagnosis Receives FDA EUA for Serology Test Capable of Determining Subjects’ past COVID-19 Exposure and Immunoresponse within 10 Minutes
THE NEWEST ASSET IN THE FIGHT AGAINST COVID-19
Global Leader in Infectious Disease Diagnosis Receives FDA EUA for Molecular Test that May Provide Laboratories Results in 83 Minutes or Less
- 1
- 2